XML 69 R55.htm IDEA: XBRL DOCUMENT v3.10.0.1
Supplemental Guarantor And Non-Guarantor Condensed Consolidating Financial Statements (Tables)
12 Months Ended
Dec. 31, 2018
Supplemental Guarantor And Non-Guarantor Condensed Consolidating Financial Statements [Abstract]  
Schedule of Condensed Income Statement
Statement of Operations Year Ended December 31, 2018
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net sales
$

 
$

 
$

 
$
14,435

 
$

 
$
14,435

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales

 

 

 
11,706

 

 
11,706

Selling, general and administrative
27

 

 

 
966

 

 
993

Amortization

 

 

 
154

 

 
154

Restructuring

 

 

 
109

 

 
109

Total operating expenses
27

 

 

 
12,935

 

 
12,962

Operating (loss) income
(27
)
 

 

 
1,500

 

 
1,473

Interest (expense) income
(141
)
 
(147
)
 
(200
)
 
(25
)
 
372

 
(141
)
Other income (expense), net

 
1

 
80

 
293

 
(372
)
 
2

(Loss) income from continuing operations before income taxes and equity income
(168
)
 
(146
)
 
(120
)
 
1,768

 

 
1,334

Income tax benefit (expense)

 

 
27

 
(277
)
 

 
(250
)
(Loss) income from continuing operations before equity income
(168
)
 
(146
)
 
(93
)
 
1,491

 

 
1,084

Equity in net income of affiliates

 

 

 
23

 

 
23

Equity in net income (loss) of subsidiaries
1,235

 
1,221

 
33

 

 
(2,489
)
 

Income (loss) from continuing operations
1,067

 
1,075

 
(60
)
 
1,514

 
(2,489
)
 
1,107

Income from discontinued operations, net of tax

 

 

 

 

 

Net income (loss)
1,067

 
1,075

 
(60
)
 
1,514

 
(2,489
)
 
1,107

Net income attributable to noncontrolling interest

 

 

 
40

 

 
40

Net income (loss) attributable to Aptiv
$
1,067

 
$
1,075

 
$
(60
)
 
$
1,474

 
$
(2,489
)
 
$
1,067

Statement of Operations Year Ended December 31, 2017
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net sales
$

 
$

 
$

 
$
12,884

 
$

 
$
12,884

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales

 

 

 
10,270

 

 
10,270

Selling, general and administrative
137

 

 

 
815

 

 
952

Amortization

 

 

 
117

 

 
117

Restructuring

 

 

 
129

 

 
129

Total operating expenses
137

 

 

 
11,331

 

 
11,468

Operating (loss) income
(137
)
 

 

 
1,553

 

 
1,416

Interest (expense) income
(255
)
 
(24
)
 
(174
)
 
(11
)
 
324

 
(140
)
Other income (expense), net

 
144

 
13

 
146

 
(324
)
 
(21
)
(Loss) income from continuing operations before income taxes and equity income
(392
)
 
120

 
(161
)
 
1,688

 

 
1,255

Income tax benefit (expense)

 

 
59

 
(282
)
 

 
(223
)
(Loss) income from continuing operations before equity income
(392
)
 
120

 
(102
)
 
1,406

 

 
1,032

Equity in net income of affiliates

 

 

 
31

 

 
31

Equity in net income (loss) of subsidiaries
1,747

 
1,623

 
62

 

 
(3,432
)
 

Income (loss) from continuing operations
1,355

 
1,743

 
(40
)
 
1,437

 
(3,432
)
 
1,063

Income from discontinued operations, net of tax

 

 

 
365

 

 
365

Net income (loss)
1,355

 
1,743

 
(40
)
 
1,802

 
(3,432
)
 
1,428

Net income attributable to noncontrolling interest

 

 

 
73

 

 
73

Net income (loss) attributable to Aptiv
$
1,355

 
$
1,743

 
$
(40
)
 
$
1,729

 
$
(3,432
)
 
$
1,355

Statement of Operations Year Ended December 31, 2016
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net sales
$

 
$

 
$

 
$
12,274

 
$

 
$
12,274

Operating expenses:
 
 
 
 
 
 
 
 
 
 
 
Cost of sales

 

 

 
9,527

 

 
9,527

Selling, general and administrative
87

 

 

 
837

 

 
924

Amortization

 

 

 
117

 

 
117

Restructuring

 

 

 
167

 

 
167

Total operating expenses
87

 

 

 
10,648

 

 
10,735

Operating (loss) income
(87
)
 

 

 
1,626

 

 
1,539

Interest (expense) income
(208
)
 
(23
)
 
(202
)
 
(67
)
 
345

 
(155
)
Other (expense) income, net
(5
)
 
(163
)
 
(11
)
 
140

 
(345
)
 
(384
)
(Loss) income from continuing operations before income taxes and equity income
(300
)
 
(186
)
 
(213
)
 
1,699

 

 
1,000

Income tax benefit (expense)
60

 

 
78

 
(305
)
 

 
(167
)
(Loss) income from continuing operations before equity income
(240
)
 
(186
)
 
(135
)
 
1,394

 

 
833

Equity in net income of affiliates

 

 

 
35

 

 
35

Equity in net income (loss) of subsidiaries
1,497

 
1,531

 
359

 

 
(3,387
)
 

Income (loss) from continuing operations
1,257

 
1,345

 
224

 
1,429

 
(3,387
)
 
868

Income from discontinued operations, net of tax

 

 

 
458

 

 
458

Net income (loss)
1,257

 
1,345

 
224

 
1,887

 
(3,387
)
 
1,326

Net income attributable to noncontrolling interest

 

 

 
69

 

 
69

Net income (loss) attributable to Aptiv
$
1,257

 
$
1,345

 
$
224

 
$
1,818

 
$
(3,387
)
 
$
1,257

Schedule of Comprehensive Income (Loss)
Statement of Comprehensive Income Year Ended December 31, 2018
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net income (loss)
$
1,067

 
$
1,075

 
$
(60
)
 
$
1,514

 
$
(2,489
)
 
$
1,107

Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Currency translation adjustments
67

 

 

 
(261
)
 

 
(194
)
Net change in unrecognized loss on derivative instruments, net of tax

 

 

 
(39
)
 

 
(39
)
Employee benefit plans adjustment, net of tax

 

 

 
2

 

 
2

Other comprehensive income (loss)
67

 

 

 
(298
)
 

 
(231
)
Equity in other comprehensive (loss) income of subsidiaries
(290
)
 
(177
)
 
25

 

 
442

 

Comprehensive income (loss)
844

 
898

 
(35
)
 
1,216

 
(2,047
)
 
876

Comprehensive income attributable to noncontrolling interests

 

 

 
32

 

 
32

Comprehensive income (loss) attributable to Aptiv
$
844

 
$
898

 
$
(35
)
 
$
1,184

 
$
(2,047
)
 
$
844

Statement of Comprehensive Income Year Ended December 31, 2017
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net income (loss)
$
1,355

 
$
1,743

 
$
(40
)
 
$
1,802

 
$
(3,432
)
 
$
1,428

Other comprehensive (loss) income:
 
 
 
 
 
 
 
 
 
 
 
Currency translation adjustments
(177
)
 

 

 
492

 

 
315

Net change in unrecognized gain on derivative instruments, net of tax

 

 

 
15

 

 
15

Employee benefit plans adjustment, net of tax

 

 

 
11

 

 
11

Other comprehensive (loss) income
(177
)
 

 

 
518

 

 
341

Equity in other comprehensive income (loss) of subsidiaries
508

 
533

 
31

 

 
(1,072
)
 

Comprehensive income (loss)
1,686

 
2,276

 
(9
)
 
2,320

 
(4,504
)
 
1,769

Comprehensive income attributable to noncontrolling interests

 

 

 
83

 

 
83

Comprehensive income (loss) attributable to Aptiv
$
1,686

 
$
2,276

 
$
(9
)
 
$
2,237

 
$
(4,504
)
 
$
1,686

Statement of Comprehensive Income Year Ended December 31, 2016
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net income (loss)
$
1,257

 
$
1,345

 
$
224

 
$
1,887

 
$
(3,387
)
 
$
1,326

Other comprehensive income (loss):
 
 
 
 
 
 
 
 
 
 
 
Currency translation adjustments
65

 

 

 
(212
)
 

 
(147
)
Net change in unrecognized gain on derivative instruments, net of tax

 

 

 
95

 

 
95

Employee benefit plans adjustment, net of tax

 

 

 
(139
)
 

 
(139
)
Other comprehensive income (loss)
65

 

 

 
(256
)
 

 
(191
)
Equity in other comprehensive (loss) income of subsidiaries
(247
)
 
(243
)
 
2

 

 
488

 

Comprehensive income (loss)
1,075

 
1,102

 
226

 
1,631

 
(2,899
)
 
1,135

Comprehensive income attributable to noncontrolling interests

 

 

 
60

 

 
60

Comprehensive income (loss) attributable to Aptiv
$
1,075

 
$
1,102

 
$
226

 
$
1,571

 
$
(2,899
)
 
$
1,075

Schedule of Condensed Balance Sheet
Balance Sheet as of December 31, 2018
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1

 
$

 
$

 
$
566

 
$

 
$
567

Restricted cash

 

 

 
1

 

 
1

Accounts receivable, net

 

 

 
2,487

 

 
2,487

Intercompany receivables, current
54

 
16

 
3,114

 
4,201

 
(7,385
)
 

Inventories

 

 

 
1,277

 

 
1,277

Other current assets

 

 

 
445

 

 
445

Total current assets
55

 
16

 
3,114

 
8,977

 
(7,385
)
 
4,777

Long-term assets:
 
 
 
 
 
 
 
 
 
 
 
Intercompany receivables, long-term

 

 
768

 
1,424

 
(2,192
)
 

Property, net

 

 

 
3,179

 

 
3,179

Investments in affiliates

 

 

 
99

 

 
99

Investments in subsidiaries
7,392

 
7,860

 
1,156

 

 
(16,408
)
 

Intangible assets, net

 

 

 
3,904

 

 
3,904

Other long-term assets

 

 
6

 
515

 

 
521

Total long-term assets
7,392

 
7,860

 
1,930

 
9,121

 
(18,600
)
 
7,703

Total assets
$
7,447

 
$
7,876

 
$
5,044

 
$
18,098

 
$
(25,985
)
 
$
12,480

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Short-term debt
$

 
$

 
$
25

 
$
281

 
$

 
$
306

Accounts payable
2

 

 

 
2,332

 

 
2,334

Intercompany payables, current
791

 
4,479

 
2,115

 

 
(7,385
)
 

Accrued liabilities
31

 

 
11

 
1,012

 

 
1,054

Total current liabilities
824

 
4,479

 
2,151

 
3,625

 
(7,385
)
 
3,694

Long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
2,953

 

 
1,055

 
30

 

 
4,038

Intercompany payables, long-term

 

 
1,296

 
896

 
(2,192
)
 

Pension benefit obligations

 

 

 
445

 

 
445

Other long-term liabilities

 

 

 
633

 

 
633

Total long-term liabilities
2,953

 

 
2,351

 
2,004

 
(2,192
)
 
5,116

Total liabilities
3,777

 
4,479

 
4,502

 
5,629

 
(9,577
)
 
8,810

Total Aptiv shareholders’ equity
3,670

 
3,397

 
542

 
12,258

 
(16,408
)
 
3,459

Noncontrolling interest

 

 

 
211

 

 
211

Total shareholders’ equity
3,670

 
3,397

 
542

 
12,469

 
(16,408
)
 
3,670

Total liabilities and shareholders’ equity
$
7,447

 
$
7,876

 
$
5,044

 
$
18,098

 
$
(25,985
)
 
$
12,480


Balance Sheet as of December 31, 2017
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
ASSETS
 
 
 
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
 
 
 
Cash and cash equivalents
$
1

 
$

 
$

 
$
1,595

 
$

 
$
1,596

Restricted cash

 

 

 
1

 

 
1

Accounts receivable, net

 

 

 
2,440

 

 
2,440

Intercompany receivables, current
50

 
16

 
82

 
9,867

 
(10,015
)
 

Inventories

 

 

 
1,083

 

 
1,083

Other current assets

 

 

 
521

 

 
521

Total current assets
51

 
16

 
82

 
15,507

 
(10,015
)
 
5,641

Long-term assets:
 
 
 
 
 
 
 
 
 
 
 
Intercompany receivables, long-term

 

 
768

 
1,366

 
(2,134
)
 

Property, net

 

 

 
2,804

 

 
2,804

Investments in affiliates

 

 

 
91

 

 
91

Investments in subsidiaries
11,987

 
11,269

 
1,925

 

 
(25,181
)
 

Intangible assets, net

 

 

 
3,163

 

 
3,163

Other long-term assets
60

 

 
8

 
402

 

 
470

Total long-term assets
12,047

 
11,269

 
2,701

 
7,826

 
(27,315
)
 
6,528

Total assets
$
12,098

 
$
11,285

 
$
2,783

 
$
23,333

 
$
(37,330
)
 
$
12,169

LIABILITIES AND SHAREHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
 
 
 
Short-term debt
$

 
$

 
$
13

 
$
4

 
$

 
$
17

Accounts payable
2

 

 

 
2,225

 

 
2,227

Intercompany payables, current
5,689

 
1,736

 
1,032

 
1,558

 
(10,015
)
 

Accrued liabilities
91

 

 
10

 
1,195

 

 
1,296

Total current liabilities
5,782

 
1,736

 
1,055

 
4,982

 
(10,015
)
 
3,540

Long-term liabilities:
 
 
 
 
 
 
 
 
 
 
 
Long-term debt
3,017

 

 
1,078

 
37

 

 
4,132

Intercompany payables, long-term

 

 
1,297

 
837

 
(2,134
)
 

Pension benefit obligations

 

 

 
454

 

 
454

Other long-term liabilities

 

 

 
526

 

 
526

Total long-term liabilities
3,017

 

 
2,375

 
1,854

 
(2,134
)
 
5,112

Total liabilities
8,799

 
1,736

 
3,430

 
6,836

 
(12,149
)
 
8,652

Total Aptiv shareholders’ equity
3,299

 
9,549

 
(647
)
 
16,279

 
(25,181
)
 
3,299

Noncontrolling interest

 

 

 
218

 

 
218

Total shareholders’ equity
3,299

 
9,549

 
(647
)
 
16,497

 
(25,181
)
 
3,517

Total liabilities and shareholders’ equity
$
12,098

 
$
11,285

 
$
2,783

 
$
23,333

 
$
(37,330
)
 
$
12,169

Schedule of Condensed Cash Flow Statement
Statement of Cash Flows for the Year Ended December 31, 2018
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net cash (used in) provided by operating activities from continuing operations
$
(170
)
 
$

 
$

 
$
1,810

 
$

 
$
1,640

Net cash used in operating activities from discontinued operations

 

 

 
(12
)
 

 
(12
)
Net cash (used in) provided by operating activities
(170
)
 

 

 
1,798

 

 
1,628

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures

 

 

 
(846
)
 

 
(846
)
Proceeds from sale of property / investments

 

 

 
13

 

 
13

Cost of business acquisitions, net of cash acquired

 

 

 
(1,197
)
 

 
(1,197
)
Cost of technology investments

 

 

 
(16
)
 

 
(16
)
Return of investment from subsidiaries
5,879

 
4,971

 

 

 
(10,850
)
 

Settlement of derivatives

 

 

 
(2
)
 

 
(2
)
Loans to affiliates

 

 

 
(3,629
)
 
3,629

 

Repayments of loans from affiliates

 

 

 
7,598

 
(7,598
)
 

Investments in subsidiaries
(100
)
 

 

 

 
100

 

Net cash provided by (used in) investing activities from continuing operations
5,779

 
4,971

 

 
1,921

 
(14,719
)
 
(2,048
)
Net cash used in investing activities from discontinued operations

 

 

 

 

 

Net cash provided by (used in) investing activities
5,779

 
4,971

 

 
1,921

 
(14,719
)
 
(2,048
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Net proceeds under other short-term debt agreements

 

 

 
255

 

 
255

Contingent consideration and deferred acquisition purchase price payments

 

 

 
(13
)
 

 
(13
)
Dividend payments of consolidated affiliates to minority shareholders

 

 

 
(30
)
 

 
(30
)
Proceeds from borrowings from affiliates
1,002

 
2,627

 

 

 
(3,629
)
 

Payments on borrowings from affiliates
(5,879
)
 
(1,719
)
 

 

 
7,598

 

Investment from parent

 

 

 
100

 
(100
)
 

Dividends paid to affiliates

 
(5,879
)
 

 
(4,971
)
 
10,850

 

Repurchase of ordinary shares
(499
)
 

 

 

 

 
(499
)
Distribution of cash dividends
(233
)
 

 

 

 

 
(233
)
Taxes withheld and paid on employees’ restricted share awards

 

 

 
(35
)
 

 
(35
)
Net cash (used in) provided by financing activities
(5,609
)
 
(4,971
)
 

 
(4,694
)
 
14,719

 
(555
)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash

 

 

 
(54
)
 

 
(54
)
Decrease in cash, cash equivalents and restricted cash

 

 

 
(1,029
)
 

 
(1,029
)
Cash, cash equivalents and restricted cash at beginning of year
1

 

 

 
1,596

 

 
1,597

Cash, cash equivalents and restricted cash at end of year
$
1

 
$

 
$

 
$
567

 
$

 
$
568

Cash, cash equivalents and restricted cash of discontinued operations
$

 
$

 
$

 
$

 
$

 
$

Cash, cash equivalents and restricted cash of continuing operations
$
1

 
$

 
$

 
$
567

 
$

 
$
568

Statement of Cash Flows for the Year Ended December 31, 2017
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net cash (used in) provided by operating activities from continuing operations
$
(93
)
 
$
(184
)
 
$

 
$
1,383

 
$

 
$
1,106

Net cash provided by operating activities from discontinued operations

 

 

 
362

 

 
362

Net cash (used in) provided by operating activities
(93
)
 
(184
)
 

 
1,745

 

 
1,468

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures

 

 

 
(698
)
 

 
(698
)
Proceeds from sale of property / investments

 

 

 
7

 

 
7

Cost of business acquisitions, net of cash acquired

 

 

 
(324
)
 

 
(324
)
Cost of technology investments

 

 

 
(50
)
 

 
(50
)
Settlement of derivatives

 

 

 
(28
)
 

 
(28
)
Loans to affiliates

 
(126
)
 

 
(986
)
 
1,112

 

Repayments of loans from affiliates

 

 

 
1,345

 
(1,345
)
 

Net cash used in investing activities from continuing operations

 
(126
)
 

 
(734
)
 
(233
)
 
(1,093
)
Net cash used in investing activities from discontinued operations

 

 

 
(159
)
 

 
(159
)
Net cash used in investing activities

 
(126
)
 

 
(893
)
 
(233
)
 
(1,252
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Net repayments under other short-term debt agreements

 

 

 
(17
)
 

 
(17
)
Contingent consideration and deferred acquisition purchase price payments

 

 

 
(24
)
 

 
(24
)
Dividend payments of consolidated affiliates to minority shareholders

 

 

 
(38
)
 

 
(38
)
Proceeds from issuance of senior notes, net of issuance costs

 

 

 
796

 

 
796

Proceeds from borrowings from affiliates
802

 
310

 

 

 
(1,112
)
 

Payments on borrowings from affiliates
(1,345
)
 

 

 

 
1,345

 

Repurchase of ordinary shares
(383
)
 

 

 

 

 
(383
)
Distribution of cash dividends
(310
)
 

 

 

 

 
(310
)
Dividend received from spin-off of Delphi Technologies
1,148

 

 

 

 

 
1,148

Cash transferred from Delphi Technologies related to spin-off
180

 

 

 

 

 
180

Cash transferred to Delphi Technologies related to spin-off

 

 

 
(863
)
 

 
(863
)
Taxes withheld and paid on employees’ restricted share awards

 

 

 
(33
)
 

 
(33
)
Net cash provided by (used in) financing activities
92

 
310

 

 
(179
)
 
233

 
456

Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash

 

 

 
86

 

 
86

(Decrease) increase in cash, cash equivalents and restricted cash
(1
)
 

 

 
759

 

 
758

Cash, cash equivalents and restricted cash at beginning of year
2

 

 

 
837

 

 
839

Cash, cash equivalents and restricted cash at end of year
$
1

 
$

 
$

 
$
1,596

 
$

 
$
1,597

Cash, cash equivalents and restricted cash of discontinued operations
$

 
$

 
$

 
$

 
$

 
$

Cash, cash equivalents and restricted cash of continuing operations
$
1

 
$

 
$

 
$
1,596

 
$

 
$
1,597

Statement of Cash Flows for the Year Ended December 31, 2016
 
Parent
 
Subsidiary Guarantors
 
Subsidiary Issuer/Guarantor
 
Non-Guarantor Subsidiaries
 
Eliminations
 
Consolidated
 
(in millions)
Net cash (used in) provided by operating activities from continuing operations
$
(141
)
 
$
125

 
$

 
$
1,510

 
$

 
$
1,494

Net cash provided by operating activities from discontinued operations

 

 

 
447

 

 
447

Net cash (used in) provided by operating activities
(141
)
 
125

 

 
1,957

 

 
1,941

Cash flows from investing activities:
 
 
 
 
 
 
 
 
 
 
 
Capital expenditures

 

 

 
(657
)
 

 
(657
)
Proceeds from sale of property / investments

 

 

 
19

 

 
19

Net proceeds from divestiture of discontinued operations

 

 

 
48

 

 
48

Proceeds from business divestitures

 

 

 
197

 

 
197

Cost of business acquisitions, net of cash acquired

 

 
(15
)
 

 

 
(15
)
Cost of technology investments

 

 
(3
)
 

 

 
(3
)
Settlement of derivatives

 

 

 
(1
)
 

 
(1
)
Loans to affiliates

 
(979
)
 

 
(1,346
)
 
2,325

 

Repayments of loans from affiliates

 

 

 
353

 
(353
)
 

Investments in subsidiaries
(854
)
 

 
(350
)
 

 
1,204

 

Net cash (used in) provided by investing activities from continuing operations
(854
)
 
(979
)
 
(368
)
 
(1,387
)
 
3,176

 
(412
)
Net cash used in investing activities from discontinued operations

 

 

 
(166
)
 

 
(166
)
Net cash (used in) provided by investing activities
(854
)
 
(979
)
 
(368
)
 
(1,553
)
 
3,176

 
(578
)
Cash flows from financing activities:
 
 
 
 
 
 
 
 
 
 
 
Net repayments under other short-term debt agreements

 

 

 
(34
)
 

 
(34
)
Repayment of senior notes

 

 
(862
)
 

 

 
(862
)
Proceeds from issuance of senior notes, net of issuance costs
852

 

 

 

 

 
852

Contingent consideration and deferred acquisition purchase price payments

 

 

 
(4
)
 

 
(4
)
Dividend payments of consolidated affiliates to minority shareholders

 

 

 
(42
)
 

 
(42
)
Proceeds from borrowings from affiliates
1,095

 

 
1,230

 

 
(2,325
)
 

Payments on borrowings from affiliates
(353
)
 

 

 

 
353

 

Investment from parent
350

 
854

 

 

 
(1,204
)
 

Repurchase of ordinary shares
(634
)
 

 

 

 

 
(634
)
Distribution of cash dividends
(317
)
 

 

 

 

 
(317
)
Taxes withheld and paid on employees’ restricted share awards

 

 

 
(40
)
 

 
(40
)
Net cash provided by (used in) financing activities
993

 
854

 
368

 
(120
)
 
(3,176
)
 
(1,081
)
Effect of exchange rate fluctuations on cash, cash equivalents and restricted cash

 

 

 
(23
)
 

 
(23
)
(Decrease) increase in cash, cash equivalents and restricted cash
(2
)
 

 

 
261

 

 
259

Cash, cash equivalents and restricted cash at beginning of year
4

 

 

 
576

 

 
580

Cash, cash equivalents and restricted cash at end of year
$
2

 
$

 
$

 
$
837

 
$

 
$
839

Cash, cash equivalents and restricted cash of discontinued operations
$

 
$

 
$

 
$
101

 
$

 
$
101

Cash, cash equivalents and restricted cash of continuing operations
$
2

 
$

 
$

 
$
736

 
$

 
$
738